Skip to main content

Find Clinical Trials

Home
Conditions
Allergic Rhinoconjunctivitis

Clinical trial condition

Allergic Rhinoconjunctivitis

Explore clinical trials studying Allergic Rhinoconjunctivitis. Study availability and eligibility vary by location and protocol.

60 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Allergic Rhinoconjunctivitis trial results

Completed

A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

NCT02481856

Conditions: Allergic Rhinoconjunctivitis
Locations: Inflamax Research Inc. Mississauga, Ontario, Canada

View Trial Details

Completed

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

NCT00841256

Conditions: Allergic Rhinoconjunctivitis
Locations: Klinik für Paediatrie Universitätsmedizin Berlin Berlin, State of Berlin, Germany

View Trial Details

Completed

Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts

NCT02506998

Conditions: Allergic Rhinoconjunctivitis
Locations: Not specified

View Trial Details

Completed

Vitamin D and Grass Pollen Specific Immunotherapy

NCT01466465

Conditions: Allergic Rhinoconjunctivitis
Locations: Charité Universitätsmedizin Berlin, Allergy-Centre-Charité, CCM Berlin, Germany

View Trial Details

Completed

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

NCT01454531

Conditions: Allergic Rhinoconjunctivitis
Locations: Hospital de Basurto Bilbao, Spain

Fundación Jiménez Diaz Madrid, Spain

Hospital Infanta Elena Madrid, Spain

Hospital Universitari Politecnic La Fe Valencia, Spain

View all 20 locations

View Trial Details

Completed

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

NCT01085526

Conditions: Allergic Rhinoconjunctivitis
Locations: Not specified

View Trial Details

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

NCT02069535

Conditions: Allergic Rhinoconjunctivitis
Locations: Hospital Clinico Universitario San Carlos Madrid, Spain

View Trial Details

Completed

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

NCT01707069

Conditions: Allergic Rhinoconjunctivitis
Locations: East West Medical Research Institute Honolulu, Hawaii, United States

View Trial Details

Completed

Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis

NCT02131051

Conditions: Allergic Rhinoconjunctivitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: HNO Praxis Elmshorn Elmshorn, Germany

View Trial Details

Completed

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

NCT01966224

Conditions: Allergic Rhinoconjunctivitis
Locations: East West Medical Research Institute Honolulu, Hawaii, United States

View Trial Details